Does LOMITAPIDE Cause Therapy cessation? 828 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 828 reports of Therapy cessation have been filed in association with LOMITAPIDE (Juxtapid). This represents 21.9% of all adverse event reports for LOMITAPIDE.
828
Reports of Therapy cessation with LOMITAPIDE
21.9%
of all LOMITAPIDE reports
4
Deaths
108
Hospitalizations
How Dangerous Is Therapy cessation From LOMITAPIDE?
Of the 828 reports, 4 (0.5%) resulted in death, 108 (13.0%) required hospitalization, and 7 (0.8%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOMITAPIDE. However, 828 reports have been filed with the FAERS database.
What Other Side Effects Does LOMITAPIDE Cause?
Diarrhoea (1,071)
Weight decreased (828)
Nausea (567)
Abdominal pain upper (280)
Flatulence (244)
Abdominal discomfort (228)
Vomiting (211)
Off label use (206)
Fatigue (200)
Drug dose omission (185)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
SECUKINUMAB (620)
Which LOMITAPIDE Alternatives Have Lower Therapy cessation Risk?
LOMITAPIDE vs LOMUSTINE
LOMITAPIDE vs LONAPEGSOMATROPIN-TCGD
LOMITAPIDE vs LONCASTUXIMAB TESIRINE-LPYL
LOMITAPIDE vs LOPERAMIDE
LOMITAPIDE vs LOPINAVIR